Cutter Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-628,677
| Closed | -$12.1M | – | 31 |
|
|
2024
Q4 | $12.1M | Buy |
628,677
+110,000
| +21% | +$2.11M | 4.94% | 10 |
|
|
2024
Q3 | $11.8M | Buy |
+518,677
| New | +$11.8M | 3.48% | 14 |
|
|
2024
Q2 | – | Sell |
-278,638
| Closed | -$4.88M | – | 37 |
|
|
2024
Q1 | $4.88M | Sell |
278,638
-29,083
| -9% | -$509K | 1.87% | 21 |
|
|
2023
Q4 | $6.7M | Buy |
+307,721
| New | +$6.7M | 3.2% | 17 |
|